Lycopodium Limited
LYOPF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $333,936 | $344,549 | $323,879 | $228,711 |
| % Growth | -3.1% | 6.4% | 41.6% | – |
| Cost of Goods Sold | $26,245 | $32,064 | $243,534 | $186,334 |
| Gross Profit | $307,691 | $312,486 | $80,345 | $42,377 |
| % Margin | 92.1% | 90.7% | 24.8% | 18.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $146,034 | $127,851 | $115,767 | $86,977 |
| SG&A Expenses | $146,034 | $127,851 | $18,552 | $15,887 |
| Sales & Mktg Exp. | $0 | $0 | -$97,215 | -$71,090 |
| Other Operating Expenses | $108,543 | $120,981 | $4,889 | -$9,836 |
| Operating Expenses | $254,577 | $248,832 | $23,441 | $6,051 |
| Operating Income | $53,114 | $63,653 | $56,904 | $36,326 |
| % Margin | 15.9% | 18.5% | 17.6% | 15.9% |
| Other Income/Exp. Net | $7,391 | $6,082 | -$2,944 | $11,316 |
| Pre-Tax Income | $60,505 | $69,736 | $61,214 | $39,128 |
| Tax Expense | $18,026 | $18,803 | $17,718 | $12,075 |
| Net Income | $42,218 | $50,714 | $46,780 | $27,178 |
| % Margin | 12.6% | 14.7% | 14.4% | 11.9% |
| EPS | 1.06 | 1.28 | 1.18 | 0.68 |
| % Growth | -17.2% | 8.5% | 73.5% | – |
| EPS Diluted | 1.06 | 1.28 | 1.18 | 0.68 |
| Weighted Avg Shares Out | 39,740 | 39,740 | 39,740 | 39,740 |
| Weighted Avg Shares Out Dil | 39,740 | 39,740 | 39,740 | 39,740 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,431 | $3,429 | $1,650 | $563 |
| Interest Expense | $370 | $760 | $839 | $886 |
| Depreciation & Amortization | $6,945 | $6,571 | $6,367 | $5,621 |
| EBITDA | $67,821 | $76,384 | $68,419 | $45,635 |
| % Margin | 20.3% | 22.2% | 21.1% | 20% |